Canine atopic dermatitis is a chronic allergic skin disease causing persistent itch and discomfort. Modern treatments have transformed welfare outcomes for affected dogs.
Canine atopic dermatitis causes genuine, significant suffering that was historically poorly controlled. Chronic itch is not a minor inconvenience — research confirms that persistent pruritus causes psychological distress comparable to chronic pain, affecting sleep, social behavior, and quality of life. The development of targeted cytokine-blocking medications has transformed welfare outcomes for atopic dogs: oclacitinib provides rapid itch relief within 24 hours, and lokivetmab provides monthly injection relief without daily medication burden. These advances mean that atopic dogs who previously lived with poorly controlled chronic itch can now achieve comfortable lives. Concurrent management of secondary infections, barrier skin care, and environmental modification optimize outcomes alongside targeted antipruritic therapy.